Fatima Al-Shahrour (Madrid, 1975) obtained her PhD from Universidad Autónoma de Madrid (UAM) in 2006. During her PhD she worked at the Bioinformatics Unit at Spanish National Cancer Research Center (CNIO, Madrid, Spain) and Centro de Investigaciones Príncipe Valencia (Valencia, Spain) under Dr. Joaquín Dopazo supervision.
During this period, her research work dealt with the development of new Bioinformatics tools for microarray gene expression analysis, with a particular focus on computational methods for the functional interpretation of high-throughput experiments.
In 2007, she was awarded with the José Castillejo mobility research grant from the Spanish Ministry of Science and Innovation to join the Computational Biology and Bioinformatics group at Cancer Program under supervision of Prf. Dr. Jill P. Mesirov at Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard (Cambridge, USA). Her project was focusing mainly in the development of a computational methodology for identifying molecular signatures of oncogenes and tumor suppressor genes based on gene expression data.
In 2008, she got a staff position at Broad Institute of MIT and Harvard as a Computational Biologist working at Dr. MD. Benjamin L. Ebert’s lab at Brigham Women’s Hospital (BWH, Boston). During this period, her research was focused on the study the biology and treatment of cancer under a genomic perspective using hematopoiesis as a model system.
After four years at the Broad Institute of MIT and Harvard and Brigham and Women Hospital, in 2012 she joined the CNIO to lead the Translational Bioinformatics Unit (TBU) in the Clinical Research Programme and Structural and Biocomputing Programme and since 2017, she is leading the Bioinformatics Unit at CNIO.
As result of her scientific career, she has published 57 papers in peer-reviewed journals and 7 book chapters.